drugset / Trial / NCT01805115

Misoprostol Administration Before Operative Hysteroscopy

NCT01805115

Phase 3 Completed 120 enrolled CHA University
RandomizedParallel-groupTriple-blindTreatment

Summary

The objective of this study is to compare the efficacy of oral, sublingual, vaginal, and no misoprostol prior to operative hysteroscopy in premenopausal women.

Timeline

Start
2013-03
Primary completion
2014-01
Completion
2014-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Misoprostol Other / unclassified 400 ug Oral

Indications